XML 39 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues:    
Revenue $ 38,461 $ 35,089
Costs and expenses:    
Cost of revenues 4 88
Sales and marketing 1,215 3,241
Research and development 1,380 4,150
General and administrative 11,442 9,835
Total costs and expenses 14,041 17,314
Operating income 24,420 17,775
Interest and other income (loss), net 2,838 374
Other income (expense), net (293) (859)
Income before benefit from (provision for) income taxes 26,965 17,290
Benefit from (provision for) income taxes 3,699 (4,806)
Net income $ 30,664 $ 12,484
Basic net income (loss) per share (in dollars per share) $ 0.92 $ 0.40
Shares used in calculating basic net income (loss) per share (in shares) 33,280 31,459
Diluted net income (loss) per share (in dollars per share) $ 0.92 $ 0.39
Shares used in calculating diluted net income (loss) per share (in shares) 33,508 31,769
Deferred gains (losses) on available-for-sale marketable debt securities $ (944) $ 290
Realized gains on available-for-sale marketable debt securities reclassified to net income 734 0
Total comprehensive income 30,454 12,774
Accumulated Deficit    
Costs and expenses:    
Net income 30,664 12,484
Royalty and license    
Revenues:    
Revenue 38,178 34,689
Development, services, and other    
Revenues:    
Revenue $ 283 $ 400